A detailed history of Rafferty Asset Management, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 311,686 shares of DVAX stock, worth $3.55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
311,686
Previous 697,907 55.34%
Holding current value
$3.55 Million
Previous $8.66 Million 59.59%
% of portfolio
0.01%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.73 - $12.58 $4.14 Million - $4.86 Million
-386,221 Reduced 55.34%
311,686 $3.5 Million
Q1 2024

May 13, 2024

BUY
$11.7 - $14.98 $1.84 Million - $2.36 Million
157,588 Added 29.17%
697,907 $8.66 Million
Q4 2023

Feb 13, 2024

BUY
$13.09 - $14.98 $833,636 - $954,001
63,685 Added 13.36%
540,319 $7.55 Million
Q3 2023

Nov 13, 2023

BUY
$12.64 - $14.99 $626,413 - $742,874
49,558 Added 11.6%
476,634 $7.04 Million
Q2 2023

Aug 11, 2023

SELL
$9.85 - $13.17 $1.12 Million - $1.5 Million
-113,963 Reduced 21.06%
427,076 $5.52 Million
Q1 2023

May 11, 2023

SELL
$9.44 - $11.88 $999,205 - $1.26 Million
-105,848 Reduced 16.36%
541,039 $5.31 Million
Q4 2022

Feb 13, 2023

BUY
$10.27 - $13.29 $534,758 - $692,010
52,070 Added 8.75%
646,887 $6.88 Million
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $3.28 Million - $5.76 Million
330,400 Added 124.95%
594,817 $6.21 Million
Q2 2022

Aug 12, 2022

SELL
$7.45 - $12.83 $2.12 Million - $3.64 Million
-284,004 Reduced 51.79%
264,417 $3.33 Million
Q1 2022

May 13, 2022

BUY
$9.75 - $14.44 $1.49 Million - $2.21 Million
152,838 Added 38.64%
548,421 $5.95 Million
Q4 2021

Feb 10, 2022

BUY
$13.17 - $20.94 $2.87 Million - $4.57 Million
218,022 Added 122.79%
395,583 $5.57 Million
Q3 2021

Nov 10, 2021

SELL
$9.16 - $19.83 $976,364 - $2.11 Million
-106,590 Reduced 37.51%
177,561 $3.41 Million
Q2 2021

Aug 10, 2021

SELL
$7.25 - $10.99 $461,448 - $699,491
-63,648 Reduced 18.3%
284,151 $2.8 Million
Q1 2021

May 10, 2021

BUY
$4.57 - $11.18 $985,314 - $2.41 Million
215,605 Added 163.1%
347,799 $3.42 Million
Q4 2020

Feb 10, 2021

SELL
$3.73 - $5.6 $984,138 - $1.48 Million
-263,844 Reduced 66.62%
132,194 $588,000
Q3 2020

Nov 13, 2020

BUY
$4.32 - $11.7 $1.46 Million - $3.95 Million
337,240 Added 573.56%
396,038 $1.71 Million
Q2 2020

Aug 07, 2020

BUY
$2.94 - $9.1 $141,872 - $439,129
48,256 Added 457.75%
58,798 $522,000
Q1 2020

May 15, 2020

SELL
$2.27 - $6.2 $179,261 - $489,614
-78,970 Reduced 88.22%
10,542 $37,000
Q4 2019

Feb 10, 2020

BUY
$3.46 - $6.93 $309,711 - $620,318
89,512 New
89,512 $512,000
Q2 2019

Aug 09, 2019

SELL
$3.65 - $7.89 $656,091 - $1.42 Million
-179,751 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$7.08 - $12.09 $1.27 Million - $2.17 Million
179,751 New
179,751 $1.31 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.44B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.